4//SEC Filing
Donovan Michael Patrick 4
Accession 0000805928-24-000044
CIK 0000805928other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 9:22 PM ET
Size
20.0 KB
Accession
0000805928-24-000044
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Donovan Michael Patrick
VP Operations
Transactions
- Exercise/Conversion
Common Stock
2024-03-16+3,000→ 38,708 total - Sale
Common Stock
2024-03-21$7.68/sh−716$5,499→ 37,992 total - Sale
Common Stock
2024-03-21$7.68/sh−4,596$35,297→ 54,250 total - Exercise/Conversion
Common Stock
2024-03-16+18,625→ 58,846 total - Exercise/Conversion
Restricted Stock Units
2024-03-16−3,000→ 0 total→ Common Stock (3,000 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-16−18,625→ 18,625 total→ Common Stock (18,625 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-16−2,950→ 2,950 total→ Common Stock (2,950 underlying) - Exercise/Conversion
Common Stock
2024-03-16+2,950→ 40,942 total - Sale
Common Stock
2024-03-21$7.68/sh−721$5,537→ 40,221 total
Footnotes (6)
- [F1]This reflects the number of restricted stock units that became vested as of March 16, 2024.
- [F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F3]Each restricted stock unit represents a contingent right to receive one share of AxoGen, Inc. common stock.
- [F4]All shares of Axogen Inc. common stock underlying the restricted stock units vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
- [F5]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023, 25% of the aggregate shares vest on March 16, 2024, and 25% of the aggregate shares vest on March 16, 2025. Vested shares will be delivered to the reporting person upon the vesting date.
- [F6]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
Documents
Issuer
Axogen, Inc.
CIK 0000805928
Entity typeother
Related Parties
1- filerCIK 0001653918
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 9:22 PM ET
- Size
- 20.0 KB